Clinical Trials Browser

Carcinoma, Squamous Cell

NCT01602380 2026-02-27

FALCON

Phase 3 Completed

462 enrolled 20 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT05377554 2026-02-27

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

Phase 3 Completed

154 enrolled

Tumor-Agnostic

Neoplasms

NCT03976362 2026-02-25

KEYLYNK-008

Phase 3 Completed

851 enrolled 25 charts

Tumor-Agnostic

Carcinoma

NCT03578081 2025-04-06

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

690 enrolled 17 charts

Tumor-Agnostic

Neoplasms

NCT02492711 2025-03-17

SOPHIA

Phase 3 Completed

624 enrolled 17 charts 2 FDA

Tumor-Agnostic

Neoplasm Metastasis

NCT03764293 2024-02-06

A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Phase 3 Completed

543 enrolled 13 charts

Tumor-Agnostic

Neoplasm Metastasis

NCT04613830 2023-02-03

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Phase 3 Completed

60 enrolled

Tumor-Agnostic

Neoplasms

NCT03665441 2022-10-18

Trybeca-1

Phase 3 Completed

512 enrolled 19 charts

Tumor-Agnostic

Neoplasms

NCT00625378 2022-09-01

STEP

Phase 3 Completed

206 enrolled 17 charts

Tumor-Agnostic

Neoplasms

NCT02625610 2022-06-09

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Phase 3 Completed

499 enrolled 22 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT03278600 2022-01-24

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

Phase 3 Completed

182 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT02367781 2021-08-09

IMpower130

Phase 3 Completed

723 enrolled 28 charts 1 FDA

Tumor-Agnostic

Carcinoma

NCT02453334 2021-05-11

IRON CLAD

Phase 3 Completed

244 enrolled 33 charts

Tumor-Agnostic

Neoplasms

NCT02583932 2021-01-08

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

Phase 3 Completed

179 enrolled

Tumor-Agnostic

Neoplasms

NCT02604225 2020-05-11

TRUSB

Phase 3 Completed

420 enrolled

Tumor-Agnostic

Neoplasms

NCT01540058 2020-02-17

GEFCAPI04

Phase 3 Completed

243 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00405522 2019-03-08

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

Phase 3 Completed

34 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT00199602 2018-08-24

Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

Phase 3 Completed

420 enrolled

Tumor-Agnostic

Neoplasms

NCT00047125 2018-07-09

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Phase 3 Completed

600 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00548548 2017-06-14

AVAGAST

Phase 3 Completed

774 enrolled 14 charts

Tumor-Agnostic

Adenocarcinoma

NCT00182754 2017-04-11

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Phase 3 Completed

33 enrolled 9 charts

Tumor-Agnostic

Neoplasm Metastasis

NCT00380406 2017-04-05

PROOF

Phase 3 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

NCT02721641 2017-03-31

A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer

Phase 3 Completed

69 enrolled 5 charts

Tumor-Agnostic

Neoplasms

NCT00565188 2016-10-25

Application of ATP Infusions in Palliative Home Care

Phase 3 Completed

100 enrolled

Tumor-Agnostic

Neoplasms

NCT00003170 2016-07-14

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

Phase 3 Completed

129 enrolled

Tumor-Agnostic

Neoplasms

NCT00003724 2016-07-12

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

Phase 3 Completed

530 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01272024 2016-06-15

TEAMS

Phase 3 Completed

146 enrolled

Tumor-Agnostic

Neoplasms

NCT01145638 2015-12-03

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Phase 3 Completed

350 enrolled 9 charts

Tumor-Agnostic

Neoplasms

NCT01011751 2015-07-30

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Phase 3 Completed

311 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT00201539 2015-04-08

Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients

Phase 3 Completed

19 enrolled

Tumor-Agnostic

Neoplasms

NCT02048098 2015-01-16

Misoprostol for Second Trimester Termination of Pregnancy

Phase 3 Completed

130 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01050829 2014-12-30

Gadobutrol Magnevist-controlled Body Study

Phase 3 Completed

370 enrolled

Tumor-Agnostic

Neoplasms

NCT00184496 2014-02-28

Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study

Phase 3 Completed

42 enrolled

Tumor-Agnostic

Neoplasms

NCT00135317 2013-05-23

AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies

Phase 3 Completed

Tumor-Agnostic

Neoplasms

NCT00193596 2013-05-03

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Phase 3 Completed

198 enrolled 7 charts

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00244868 2013-01-29

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Phase 3 Completed

720 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01081899 2013-01-14

The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.

Phase 3 Completed

308 enrolled

Tumor-Agnostic

Neoplasms

NCT00360841 2012-12-06

Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting

Phase 3 Completed

103 enrolled

Tumor-Agnostic

Neoplasms

NCT00362583 2012-05-07

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Phase 3 Completed

100 enrolled

Tumor-Agnostic

Neoplasms

NCT00140075 2011-05-26

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Phase 3 Completed

606 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT00302185 2010-10-20

Acupuncture in Palliative Cancer Care

Phase 3 Completed

20 enrolled

Tumor-Agnostic

Neoplasms

NCT00272428 2009-12-17

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Phase 3 Completed

13,000 enrolled

Tumor-Agnostic

Neoplasms

NCT00375076 2009-09-18

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

Phase 3 Completed

Tumor-Agnostic

Neoplasms

NCT00681486 2009-08-21

Phase 3

Phase 3 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

NCT00107627 2009-06-25

Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery

Phase 3 Completed

90 enrolled

Tumor-Agnostic

Neoplasms

NCT00635973 2009-04-22

Open-Label Extension of Other SZ1839 (Iressa) Trials

Phase 3 Completed

100 enrolled

Tumor-Agnostic

Neoplasms

NCT00539630 2007-10-04

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

Phase 3 Completed

86 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT00201279 2005-09-20

Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

Phase 3 Completed

342 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT00201383 2005-09-20

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

Phase 3 Completed

161 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

Clinical Trials

KEYNOTE-630

FALCON

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

KEYLYNK-008

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

SOPHIA

A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Trybeca-1

STEP

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

IMpower130

IRON CLAD

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

TRUSB

GEFCAPI04

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

AVAGAST

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

PROOF

A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer

Application of ATP Infusions in Palliative Home Care

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

TEAMS

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients

Misoprostol for Second Trimester Termination of Pregnancy

Gadobutrol Magnevist-controlled Body Study

Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study

AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.

Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Acupuncture in Palliative Cancer Care

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

Phase 3

Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery

Open-Label Extension of Other SZ1839 (Iressa) Trials

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients